Published January 31, 2019 | Version v1
Patent Open

RECURRENT FUSION GENES IN HUMAN CANCERS

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Fusion transcripts are provided herein. In exemplary embodiments, the fusion transcript is encoded by a nucleic acid molecule comprising a general structure A-B, wherein structure A is a portion of a gene listed in Column A of Table 1 and structure B is a portion of a gene listed in Column B of Table 1, wherein the gene listed in Column A and the gene listed in Column B are listed in the same row of Table 1, wherein structure B is located immediately 3′ to structure A. Polypeptides encoded by the fusion transcript, nucleic acid molecules encoding the fusion transcript, and nucleic acid molecules comprising the reverse complement sequence of the fusion transcript, are additionally provided. Related expression vectors, host cells, binding agents, kits, and methods of using the same are further provided herein.

Files

US20190033306.pdf

Files (2.0 MB)

Name Size Download all
md5:4fce4e6d24e31e5cd3cb68c76f2e20a3
2.0 MB Preview Download

Additional details

Identifiers

Patent application number
US 201515310753 A
Patent number
US 2019/0033306 A1
Other
oai:uchicago.tind.io:9378

Dates

Patent filed
2015-05-13

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Genetics, Genomics, and Systems Biology